Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 75 publications
Signaling Mutations Negate the Favorable Impact of NPM1 Mutations in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With VEN/HMA.
Journal: American journal of hematology
Published: April 02, 2026
IDH2 mutation is associated with favorable outcome among older adults with newly diagnosed acute myeloid leukemia treated with hypomethylating agent-based therapy.
Journal: Haematologica
Published: July 24, 2025
Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed NPM1-Mutated or KMT2A-Rearranged AML.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 12, 2025
Case Report: Pathologic complete response in a patient with simultaneous diagnoses of resectable NSCLC and myeloid neoplasm with PDGFRA rearrangement treated with concurrent neoadjuvant chemoimmunotherapy and imatinib: translating clinical trial data to real-world practice.
Journal: Frontiers in oncology
Published: March 06, 2025
Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial.
Journal: Blood cancer journal
Published: February 01, 2025
Real-world analysis of strategies to prevent thrombosis and bleeding in adults with ALL treated with asparaginase.
Journal: Blood vessels, thrombosis & hemostasis
Published: October 28, 2024
Evaluation of Gemtuzumab Ozogamicin and Anthracycline Dosing for Favorable Risk Acute Myeloid Leukemia.
Journal: European journal of haematology
Published: October 02, 2024
Disseminated adult xanthogranuloma in association with underlying B-cell acute lymphoblastic leukemia.
Journal: International journal of dermatology
Published: July 28, 2024
Last Updated: 09/26/2026